{"acute myeloid leukaemia": 34.11, "anaemia": 2.4, "colitis": 6.6, "cytomegalovirus infection reactivation": 36.4, "cytopenia": 20.11, "diffuse large b-cell lymphoma recurrent": 131.88, "disease progression": 14.66, "enteritis": 35.45, "febrile neutropenia": 34.86, "haematotoxicity": 62.71, "infection": 2.41, "mucosal inflammation": 30.26, "myelodysplastic syndrome": 55.22, "myelosuppression": 5.0, "neutropenia": 3.95, "neutrophil count decreased": 2.73, "non-hodgkin's lymphoma": 67.17, "non-hodgkin's lymphoma recurrent": 443.35, "off label use": 4.78, "pancytopenia": 9.69, "pneumonia": 2.58, "pneumonitis": 7.32, "product use in unapproved indication": 3.91, "product use issue": 2.27, "respiratory failure": 2.94, "second primary malignancy": 22.08, "sepsis": 4.38, "septic shock": 7.27, "stomatitis": 4.11, "thrombocytopenia": 8.94, "toxicity to various agents": 3.36, "venoocclusive liver disease": 60.66}